Andere talen PTC Therapeutics, Inc.

Aandelen

PTCT

US69366J2006

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 02-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
33,62 ^USD	-1,58%		+31,89%	+21,99%

29/04	PTC THERAPEUTICS, INC. : Morgan Stanley haalt aandeel van de verkooplijst	ZM
26/04	Sectorupdate: Gezondheidszorgaandelen randen hoger aan het eind van de middag	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

PTC Therapeutics to Participate at Upcoming Investor Conferences	02/05
North American Morning Briefing : More Earnings -2-	30/04
Sector Update: Health Care Stocks Edge Higher Late Afternoon	26/04
Sector Update: Health Care	26/04
PTC Therapeutics Shares Rise After Better-Than-Expected Q1 Results	26/04
PTC Therapeutics : Q1 2024 FLS	25/04
PTC Therapeutics: Q1 Earnings Snapshot	25/04
Earnings Flash (PTCT) PTC THERAPEUTICS Posts Q1 Revenue $210.1M, vs. Street Est of $163.8M	25/04
PTC Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results	25/04
PTC Therapeutics, Inc. Reaffirms Earnings Guidance for the Year 2024	25/04
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)	24/04
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	23/04
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results	12/04
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results	11/04
PTC Therapeutics Seeks EMA Marketing Authorization for Sepiapterin for Phenylketonuria Treatment	28/03
PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA	28/03
PTC Therapeutics, Inc. Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA	28/03
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza as a Treatment for AADC Deficiency	20/03
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza? as a Treatment for AADC Deficiency	19/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen PTC Therapeutics, Inc.

Aandelen

PTCT

US69366J2006

Andere talen

Filters